DrugDashboards

Cetirizine Hydrochloride Oral Solution

Cetirizine Hydrochloride Oral Solution · CETIRIZINE HYDROCHLORIDE 5 mg/5mL · Solution · Oral · Chartwell RX, LLC

NDC 62135-0057-41 · 120 mL in 1 BOTTLE · ANDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. The price has held steady around $0.0228 per mL over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.01$0.02$0.03Nov 2022Sep 2026$0.0228
47 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$85.00
Reported to Texas DSHS · 2026 annual filing · Chartwell RX, LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$79,057
7,464 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

10Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 3 active manufacturers+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for cetirizine hydrochloride (other) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market · price up 5% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA078876
TE code
AA
Approval date
May 11, 2012
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Cetirizine Hydrochloride Oral Solution (Solution)

LabelerStrengthFirst seenLast seen
Apozeal Pharmaceuticals IncCETIRIZINE HYDROCHLORIDE 1 mg/mLJul 15, 2026Sep 2, 2026
Chartwell RX, LLCCETIRIZINE HYDROCHLORIDE 5 mg/5mLJul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.CETIRIZINE HYDROCHLORIDE 1 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Cetirizine Hydrochloride Oral Solution — NDC 62135-0057-41," retrieved September 3, 2026, https://drugdashboards.com/drug/62135005741.

Free to cite with attribution — see how the data is put together.